Rafferty Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-312,804
Closed -$970K 1097
2025
Q4
$970K Buy
+312,804
New +$893K ﹤0.01% 805
2023
Q1
Sell
-2,771,503
Closed -$6.01M 1154
2022
Q4
$6.01M Buy
2,771,503
+2,542,058
+1,108% +$20.9M 0.05% 340
2022
Q3
$2.75M Buy
229,445
+83,699
+57% +$1.04M 0.03% 439
2022
Q2
$1.22M Sell
145,746
-44,727
-23% -$347K 0.01% 586
2022
Q1
$1.65M Buy
190,473
+6,629
+4% +$63.9K 0.01% 668
2021
Q4
$2.08M Buy
183,844
+106,084
+136% +$1.26M 0.01% 646
2021
Q3
$977K Sell
77,760
-35,090
-31% -$323K 0.01% 835
2021
Q2
$916K Sell
112,850
-60,778
-35% -$527K 0.01% 947
2021
Q1
$1.61M Buy
173,628
+148,612
+594% +$1.5M 0.01% 680
2020
Q4
$242K Sell
25,016
-22,817
-48% -$225K ﹤0.01% 923
2020
Q3
$594K Buy
47,833
+31,042
+185% +$412K 0.01% 667
2020
Q2
$218K Buy
+16,791
New +$211K ﹤0.01% 909
2020
Q1
Sell
-42,710
Closed -$668K 688
2019
Q4
$668K Buy
+42,710
New +$860K 0.01% 638

Other funds holding GOSS

Rafferty Asset Management's GOSS Position: Q1 2026 in Review

Rafferty Asset Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 312,804 shares — an estimated $970K sold.

Rafferty Asset Management first reported a position in GOSS in Q4 2019 and held it in 13 quarters. The position peaked at $6.01M in Q4 2022. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Rafferty Asset Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 312,804 Gossamer Bio shares in Q1 2026, an estimated $970K.
  • Rafferty Asset Management first reported a position in Gossamer Bio in Q4 2019 and held it in 13 quarters.
  • Rafferty Asset Management's Gossamer Bio position peaked at $6.01M in Q4 2022.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.